Prescription drug · ANDA
Aripiprazole NDC 29300-179
Aripiprazole 20 mg/1 · Tablet · Oral · Unichem Pharmaceuticals (USA), Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 29300-179-01 | 29300017901 | 100 TABLET in 1 BOTTLE, PLASTIC (29300-179-01)Marketed from Feb 21, 2022 | |
| 29300-179-05 | 29300017905 | 500 TABLET in 1 BOTTLE, PLASTIC (29300-179-05)Marketed from Feb 21, 2022 | |
| 29300-179-13 | 29300017913 | 30 TABLET in 1 BOTTLE, PLASTIC (29300-179-13)Marketed from Feb 21, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Aripiprazole
- Generic name (nonproprietary)
- aripiprazole
- Active ingredients
- Aripiprazole — 20 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 203025
- Marketing start
- Listing expires
- Identifiers
- Product ID 29300-179_f1daa6df-15e5-4f75-b656-6f99906e98e0SPL ID f1daa6df-15e5-4f75-b656-6f99906e98e0SPL set ID 349b8a7b-5ada-4f5c-a269-a86806c6b520RxCUI 349490, 349545, 349547, 349553, 402131, 602964UNII 82VFR53I78UPC 0329300180138, 0329300177138, 0329300178135, 0329300176131, 0329300179132
- Pharmacologic class
- Atypical Antipsychotic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N429300017901followed by a unit qualifier and the quantityPackage 29300-0179-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Aripiprazole tablets are indicated for the treatment of: Schizophrenia Irritability Associated with Autistic Disorder Treatment of Tourette's Disorder Aripiprazole is an atypical antipsychotic. The oral formulations are indicated for: Schizophrenia ( 14.1 ) Irritability Associated with Autistic Disorder ( 14.4 ) Treatment of Tourette's disorder ( 14.5 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 203025
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Aripiprazole | Aripiprazole 2 mg/1 | TabletOral | Unichem Pharmaceuticals (USA), Inc. | 29300-175 |
| Aripiprazole | Aripiprazole 5 mg/1 | TabletOral | Unichem Pharmaceuticals (USA), Inc. | 29300-176 |
| Aripiprazole | Aripiprazole 10 mg/1 | TabletOral | Unichem Pharmaceuticals (USA), Inc. | 29300-177 |
| Aripiprazole | Aripiprazole 15 mg/1 | TabletOral | Unichem Pharmaceuticals (USA), Inc. | 29300-178 |
| Aripiprazole | Aripiprazole 30 mg/1 | TabletOral | Unichem Pharmaceuticals (USA), Inc. | 29300-180 |